Important Regulatory Note:
NAD+ (nicotinamide adenine dinucleotide) injections are often prescribed off-label and may be prepared by licensed compounding pharmacies. These formulations are not FDA-approved and have not been evaluated for safety, effectiveness, or quality by the U.S. Food and Drug Administration.

Intended Use:
NAD+ injections may be used to support cellular metabolism, mitochondrial function, and overall wellness. They are commonly marketed for anti-aging, energy enhancement, cognitive performance, detoxification, and metabolic support. Use is based on provider evaluation and is not intended to treat, cure, or prevent any disease.

Contraindications:
Do not use NAD+ injections if:

• You have a known hypersensitivity to NAD+ or any injection components
• You are pregnant or breastfeeding unless explicitly cleared by your provider
• You have an active infection, autoimmune disorder, or cancer diagnosis not under remission, unless specifically approved by a specialist
  
  

Warnings & Serious Risks:

• Allergic reactions: May include rash, swelling, or difficulty breathing. Seek immediate medical attention if symptoms occur.
• Cardiovascular sensitivity: Rare cases of chest tightness, lightheadedness, or rapid heartbeat have been reported.
• Fatigue or dizziness: May occur during or after injection.
• Interaction with oxidative metabolism: Use caution if on medications affecting mitochondrial function.
• Photosensitivity: NAD+ may increase sensitivity to light in some individuals.
  
  

Common Side Effects:

• Injection site redness, swelling, or soreness
• Flushing or warmth
• Mild nausea
• Lightheadedness
• Temporary fatigue or dizziness

These effects are generally short-lived and mild.

Drug Interactions:
While no major interactions are well-established, use caution if you are taking:

• Insulin, metformin, or corticosteroids
• Drugs affecting mitochondrial or oxidative pathways
• High-dose antioxidants

Always disclose your full medication list to your healthcare provider before starting treatment.

Pregnancy & Breastfeeding:
NAD+ injections are not recommended during pregnancy or while breastfeeding due to insufficient safety data. Use only under the direction of a licensed provider.

Administration:
Administered via subcutaneous or intramuscular injection, as directed by your provider. Do not exceed the recommended dosage or frequency.

Storage:
Refrigerate between 36°F and 46°F (2°C to 8°C). Do not freeze. Protect from light and keep the vial sealed until use.

Emergency Situations:
Discontinue use and seek emergency medical attention if you experience chest tightness, shortness of breath, signs of an allergic reaction, or severe fatigue following injection.

Disclaimer:
This content is for educational purposes only and does not constitute medical advice. NAD+ injections are prescribed off-label and not evaluated by the FDA. Speak with your healthcare provider before beginning or modifying any treatment. Report any adverse effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.